Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Nov 2020

Wang Ran, Fan Dongying, Wang Lei, Li Yueqi, Zhou Hongning, Gao Na, An Jing

Abstract excerpt

Japanese encephalitis (JE), caused by infection with Japanese encephalitis virus (JEV), is the most important viral encephalitis in Asia. JE incidence has significantly decreased by immunization with live-attenuated vaccine SA14-14-2. However, the duration of immune response overtime after vaccination is inconclusive and may be associated with the risk of JE occurrence in adults. A cross-sectional study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Beijing
Share to Encephalitis, Japanese

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Encephalitis Virus, Japanese

Share to Endemic Diseases

Share to Immunity, Cellular

Share to Immunization

Share to Serogroup

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 32736041
DOI: 10.1016/j.meegid.2020.104476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting.PMID 32736041Read ↗

Dynamics of Lymphocyte Subsets During the Covid-19 Vaccination Process in Japanese General PopulationSemantic proximity Read ↗

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.Semantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.Semantic proximity Read ↗

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-oldsSemantic proximity Read ↗

Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in childrenSemantic proximity Read ↗

Study on the Protective Efficacy of the Japanese Encephalitis Live Attenuated Vaccine SA14-14-2 Against Newly Isolated Genotype I Japanese Encephalitis Viruses.Semantic proximity Read ↗

Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.Semantic proximity Read ↗

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.Semantic proximity Read ↗

Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humansSemantic proximity Read ↗

Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.Semantic proximity Read ↗

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.